NCT01436669View on ClinicalTrials.gov

Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Cancer
Interventions
DEVICE

Home Telemonitoring System (The Zodiac, Philips Health care)

Full blood count (FBC) home tele-monitoring system which will allow cancer patients receiving chemotherapy to test their blood count at home (haemoglobin, haematocrit, white cell count and neutrophil count).

Trial Locations (1)

Unknown

Royal Marsden Hospital, Belmont

Sponsors

Lead Sponsor

Philips Healthcare
All Listed Sponsors
collaborator

The Royal Marsden Hospital

UNKNOWN

lead

Philips Healthcare

INDUSTRY

NCT01436669 - Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient | Biotech Hunter | Biotech Hunter